一九七七年,我省药物研究所从三七绒根中,用化学方法研制出一种新药、命名为三七冠心宁,经昆明、呼和浩特,北京、成都、上海、广州、武汉七个城市,28所医院临床验证828例冠心病人,心绞痛缓解率70.18%,其中4—6月疗程者,总有效率为82.73%,硝酸甘油停减率为95.10%,缺血型心电图改善率40.64%,二级梯运动试验阴转率45%,同时对高脂血症也有相当疗效。临床和药理学研究均证实三七冠心宁是治疗冠心病的有效药物。 In 1977, the Institute of Materia Medica in our province developed a new drug by chemical method from the roots of Sanqian velvet root, named Sanqi Guanxinning, passing Kunming, Hohhot, Beijing, Chengdu, Shanghai, Guangzhou and Wuhan seven Cities and 28 hospitals clinical validation of 828 cases of coronary heart disease, angina pectoris relief rate of 70.18%, of which 4 - 6 months course, the total effective rate was 82.73%, nitroglycerin reduction rate was 95.10%, ischemic electrocardiogram improvement rate 40.64%, two ladder test negative conversion rate of 45%, while also have a considerable effect on hyperlipidemia. Clinical and pharmacological studies have confirmed that Sanqi Guanxinning is an effective drug for the treatment of coronary heart disease.